anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 60,568
Current window 38,071-38,100
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all
18 30 60

Component

38,071-38,100 of 60,568

filter-aware
30
Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
31
The table provides a breakdown of financial performance by segment, excluding certain corporate costs as noted in the footnote.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
32
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
33
Includes footnote regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
34
Includes Bausch Health logo and page number 34.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
35
Includes detailed breakdown of non-GAAP adjustments and their impact on EPS.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
Includes footnotes regarding non-GAAP measures, exchange rate impacts, and segment reporting structure.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
Includes footnotes regarding non-GAAP measures, exchange rate impacts, and segment reporting changes.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
Includes footnote disclosures regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
Includes adjustments for asset impairments, restructuring, debt extinguishment, and other non-recurring items.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
08
Industry benchmarks based on Paul et al Nat Rev Drug Discov 2010.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide uses a list-based structure to demonstrate the efficacy and speed of the AI platform, supported by external validation from The Lancet and Eli Lilly.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
16
The slide uses a hub-and-spoke diagram to link the company to its five strategic capital allocation pillars.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
12
Includes specific adjustments for mark-to-market timing differences.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide highlights financial performance improvements in the Ingredients segment, with specific callouts for revenue growth drivers and margin impacts.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
Includes footnotes regarding reconciliation and MTM timing adjustments.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations 1 hit
18
Financial data in thousands USD, except per share information.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations 1 hit
19
Financial data presented in thousands USD. The table is split into two columns: Assets on the left and Liabilities/Equity on the right.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations 1 hit
20
Standard GAAP cash flow statement format.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations 1 hit
30
The slide shows a time-series progression of cell count and secretion intensity, with a large grid of microfluidic chambers on the right.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Need1 hit
58
The slide uses a structured table format to map customer segments to specific benefits and quantitative outcomes.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
73
The slide uses a timeline visual combined with a comparison table to show product evolution.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
74
The slide maps specific chip hardware to workflow names and technical specs (capacity/volume).Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
87
The chart shows a 38% CAGR for partnership revenue from 2022 to 2025.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a Gantt-style visualization to show the clinical stage of drug candidates.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
12
Includes 'Number at Risk' table below the Kaplan-Meier plot.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
Data cut-off Oct 28, 2022. Includes definitions for W/D, NSQ, SQ, and response markers.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Data presented in a table format comparing BA3011 (N=13) and BA3011 + Opdivo (N=9).BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
27
The slide uses a table to present clinical outcomes (PR/CR) for specific tumor types, supporting the 'first-in-class' claim.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 1 hit
30
The slide uses a combination of a comparison table for clinical data and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 1 hit